CL2013003488A1 - Dispositivo intravaginal que comprende un bolsillo que contiene una matriz con un agente anticolinérgico, donde la pared del bolsillo tiene un espesor uniforme; método para la fabricación de un dispositivo intravaginal (divisional de solicitud n°3658-12)”. - Google Patents
Dispositivo intravaginal que comprende un bolsillo que contiene una matriz con un agente anticolinérgico, donde la pared del bolsillo tiene un espesor uniforme; método para la fabricación de un dispositivo intravaginal (divisional de solicitud n°3658-12)”.Info
- Publication number
- CL2013003488A1 CL2013003488A1 CL2013003488A CL2013003488A CL2013003488A1 CL 2013003488 A1 CL2013003488 A1 CL 2013003488A1 CL 2013003488 A CL2013003488 A CL 2013003488A CL 2013003488 A CL2013003488 A CL 2013003488A CL 2013003488 A1 CL2013003488 A1 CL 2013003488A1
- Authority
- CL
- Chile
- Prior art keywords
- intravaginal device
- matrix
- manufacturing
- uniform thickness
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F6/00—Contraceptive devices; Pessaries; Applicators therefor
- A61F6/06—Contraceptive devices; Pessaries; Applicators therefor for use by females
- A61F6/14—Contraceptive devices; Pessaries; Applicators therefor for use by females intra-uterine type
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
- A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F5/00—Orthopaedic methods or devices for non-surgical treatment of bones or joints; Nursing devices; Anti-rape devices
- A61F5/48—Devices for preventing wetting or pollution of the bed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/221—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having an amino group, e.g. acetylcholine, acetylcarnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/472—Non-condensed isoquinolines, e.g. papaverine
- A61K31/4725—Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
Abstract
Se divulga un dispositivo intravaginal que comprende: (a) Una primera matriz anular la cual comprende un bolsillo y una pared del bolsillo, en donde la pared del bolsillo tiene un espesor uniforme, y en donde la pared del bolsillo rodea el bolsillo, y (b) Una segunda matriz que comprende un agente anticolinérgico, en donde la segunda matriz está localizada en este bolsillo. También se divulga un método para la fabricación de un dispositivo intravaginal.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US35732110P | 2010-06-22 | 2010-06-22 |
Publications (1)
Publication Number | Publication Date |
---|---|
CL2013003488A1 true CL2013003488A1 (es) | 2014-08-08 |
Family
ID=45372075
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CL2012003658A CL2012003658A1 (es) | 2010-06-22 | 2012-12-21 | Un metodo para tratar una afeccion asociada al sindrome de vejiga hiperactiva que comprende administrar un dispositivo vaginal con a) una primera matriz anular comprendiendo un bolsillo y una pared de bolsillo y b) una segunda matriz ubicada en el bolsillo con un agente anticolinergico; dispositivo intravaginal y su metodo de fabricacion. |
CL2013003488A CL2013003488A1 (es) | 2010-06-22 | 2013-12-05 | Dispositivo intravaginal que comprende un bolsillo que contiene una matriz con un agente anticolinérgico, donde la pared del bolsillo tiene un espesor uniforme; método para la fabricación de un dispositivo intravaginal (divisional de solicitud n°3658-12)”. |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CL2012003658A CL2012003658A1 (es) | 2010-06-22 | 2012-12-21 | Un metodo para tratar una afeccion asociada al sindrome de vejiga hiperactiva que comprende administrar un dispositivo vaginal con a) una primera matriz anular comprendiendo un bolsillo y una pared de bolsillo y b) una segunda matriz ubicada en el bolsillo con un agente anticolinergico; dispositivo intravaginal y su metodo de fabricacion. |
Country Status (16)
Country | Link |
---|---|
US (1) | US20120107385A1 (es) |
EP (1) | EP2585010A4 (es) |
JP (1) | JP2013534923A (es) |
KR (1) | KR20130118296A (es) |
CN (1) | CN103153245A (es) |
AR (1) | AR084700A1 (es) |
AU (1) | AU2011270995A1 (es) |
CA (1) | CA2803872A1 (es) |
CL (2) | CL2012003658A1 (es) |
EA (1) | EA201291299A1 (es) |
MX (1) | MX2013000002A (es) |
PE (1) | PE20130639A1 (es) |
SG (2) | SG10201504871PA (es) |
TW (1) | TW201212910A (es) |
WO (1) | WO2011163356A2 (es) |
ZA (1) | ZA201209757B (es) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2940478T3 (es) * | 2014-06-26 | 2023-05-08 | Taris Biomedical Llc | Dispositivos de administración de fármacos intravesicales y métodos que incluyen sistemas de matriz de polímero-fármaco elásticos |
KR20210039403A (ko) * | 2018-08-01 | 2021-04-09 | 타리스 바이오메디컬 엘엘씨 | 트로스피움을 사용한 과민성 방광의 치료 방법 |
KR20220146361A (ko) * | 2021-04-23 | 2022-11-01 | 김승범 | 과민성 방광 치료 장치 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL48277A (en) * | 1974-10-18 | 1978-03-10 | Schering Ag | Vaginal ring |
US5972372A (en) * | 1996-07-31 | 1999-10-26 | The Population Council, Inc. | Intravaginal rings with insertable drug-containing core |
DE69929055T2 (de) * | 1998-05-01 | 2006-07-20 | Duramed Pharmaceuticals Inc., Cincinnati | Verfahren zur spritzgussherstellung von vorrichtungen mit kontrollierter wirkstofffreisetzung und damit hergestellte vorrichtung |
US6436428B1 (en) * | 2000-03-21 | 2002-08-20 | Enhance Pharmaceuticals, Inc. | Device and method for treating urinary incontinence in females |
CA2471400A1 (en) * | 2001-12-20 | 2003-07-03 | Femmepharma, Inc. | Vaginal delivery of drugs |
US7005138B2 (en) * | 2001-12-21 | 2006-02-28 | Duramed Pharmaceuticals, Inc. | Method of systematically delivering SSRIs |
WO2005004837A1 (en) * | 2003-07-10 | 2005-01-20 | Galen (Chemicals) Limited | Intravaginal drug delivery devices |
WO2006084083A2 (en) * | 2005-02-03 | 2006-08-10 | Duramed Pharmaceuticals, Inc. | Devices for delivering agents to a vaginal tract |
US20100040671A1 (en) * | 2008-08-12 | 2010-02-18 | Ahmed Salah U | Intravaginal Devices With a Rigid Support, Methods of Making, and Uses Thereof |
-
2001
- 2001-07-27 MX MX2013000002A patent/MX2013000002A/es not_active Application Discontinuation
-
2011
- 2011-06-22 CN CN2011800313890A patent/CN103153245A/zh active Pending
- 2011-06-22 CA CA2803872A patent/CA2803872A1/en not_active Abandoned
- 2011-06-22 PE PE2012002492A patent/PE20130639A1/es not_active Application Discontinuation
- 2011-06-22 SG SG10201504871PA patent/SG10201504871PA/en unknown
- 2011-06-22 AU AU2011270995A patent/AU2011270995A1/en not_active Abandoned
- 2011-06-22 KR KR1020137001335A patent/KR20130118296A/ko not_active Application Discontinuation
- 2011-06-22 SG SG2012095246A patent/SG186815A1/en unknown
- 2011-06-22 WO PCT/US2011/041444 patent/WO2011163356A2/en active Application Filing
- 2011-06-22 TW TW100121861A patent/TW201212910A/zh unknown
- 2011-06-22 JP JP2013516731A patent/JP2013534923A/ja active Pending
- 2011-06-22 AR ARP110102163A patent/AR084700A1/es unknown
- 2011-06-22 EA EA201291299A patent/EA201291299A1/ru unknown
- 2011-06-22 EP EP11798840.2A patent/EP2585010A4/en not_active Withdrawn
- 2011-06-22 US US13/166,302 patent/US20120107385A1/en not_active Abandoned
-
2012
- 2012-12-21 ZA ZA2012/09757A patent/ZA201209757B/en unknown
- 2012-12-21 CL CL2012003658A patent/CL2012003658A1/es unknown
-
2013
- 2013-12-05 CL CL2013003488A patent/CL2013003488A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
MX2013000002A (es) | 2013-04-29 |
CA2803872A1 (en) | 2011-12-29 |
AU2011270995A1 (en) | 2013-01-10 |
AR084700A1 (es) | 2013-06-05 |
EP2585010A4 (en) | 2014-10-01 |
US20120107385A1 (en) | 2012-05-03 |
KR20130118296A (ko) | 2013-10-29 |
TW201212910A (en) | 2012-04-01 |
JP2013534923A (ja) | 2013-09-09 |
WO2011163356A2 (en) | 2011-12-29 |
SG10201504871PA (en) | 2015-07-30 |
EP2585010A2 (en) | 2013-05-01 |
EA201291299A1 (ru) | 2013-09-30 |
CL2012003658A1 (es) | 2014-02-14 |
CN103153245A (zh) | 2013-06-12 |
PE20130639A1 (es) | 2013-06-15 |
ZA201209757B (en) | 2015-06-24 |
WO2011163356A3 (en) | 2012-03-22 |
SG186815A1 (en) | 2013-02-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PE20201177A1 (es) | Tarjeta de transaccion con componentes electronicos incorporados y procedimiento para su fabricacion | |
AR082304A1 (es) | Un agente de sosten | |
CO2017005701A2 (es) | Un método de comunicación, un dispositivo de almacenamiento legible por computadora y un aparato para la comunicación | |
GT200800293AA (es) | Matriz de expansión y metodo para moldear recipientes (solicitud divisional derivada de la solicitud de patente número a-2008-00293) | |
AR086945A1 (es) | Material polimerico para un recipiente aislante | |
SV2016005214A (es) | Sistema de administración farmacológico | |
AR072366A1 (es) | Metodo de preparacion de unidades aglutinantes revestidas | |
CL2012003720A1 (es) | Anillo de empuje para un tren de rodaje en una maquina de cadenas que comprende un cuerpo anular con un borde exterior circular y un borde interior circular, una primera y segunda superficies de empuje con un conjunto de ranuras para aceite respectivamente que se extienden a partir del borde interior hasta el borde exterior; y metodo. | |
ES2570633T3 (es) | Método para detectar células | |
MX2016012961A (es) | Dispositivos de aislamiento con una matriz de anodo y un catodo de fibra. | |
CL2008000997A1 (es) | Metodo de tratamiento que comprende administrar un agente farmaceutico activable con capacidad de efectuar un cambio celular al activarse, aplicar una energia iniciadora, donde el cambio celular trata el trastorno de proliferacion celular; metodo de | |
CL2012001019A1 (es) | Composicion farmaceutica que comprende una proenzima de proteasa seleccionada de al menos tripsinogeno y quimiotripsinogeno y un agente activo seleccionado de al menos un compuesto de selenio, un compuesto vanilloide, un agente reductor de glicolisis citoplasmica y opcionalmente una glucosidohidrolasa; y uso para tratar cancer. | |
CL2013002626A1 (es) | Artículo para fumar que comprende una primera parte y una segunda parte movil en relacion con la primera parte, y ademas un mecanismo de control que comprende una primera superficie de control y una segunda superficie de control; metodo de fabricacion del articulo para fumar. | |
CL2020000332A1 (es) | Composición a utilizar a la hora de formar un material polimérico que estabiliza una pared de un pozo. (divisional solicitud 2019000252) | |
CL2014001490A1 (es) | Sistema mecanico que comprende una pieza de desgaste y un soporte, donde dicho soporte comprende una base, un saliente, una cavidad de recepcion de una oreja, y una primera y segunda zona con al menos seis caras planas opuestas; cangilon. | |
CL2014003055A1 (es) | Procedimiento para preparar una composicion farmaceutica que comprende i) proporcionar una primera combinacion que comprende un compuesto inhibidor del proteasoma peptidico, una o mas ciclodextrinas y agua, y ii) poner en contacto la primera combinacion con un acido para formar una segunda combinacion; composicion farmaceutica. | |
BR112017028591A2 (pt) | técnicas para relatar condição de armazenador em comunicações sem fio | |
CU24285B1 (es) | Método y ensamble para la fabricación de artículos alargados de concreto | |
CL2013003488A1 (es) | Dispositivo intravaginal que comprende un bolsillo que contiene una matriz con un agente anticolinérgico, donde la pared del bolsillo tiene un espesor uniforme; método para la fabricación de un dispositivo intravaginal (divisional de solicitud n°3658-12)”. | |
CL2012002038A1 (es) | Metodo para reducir la presion intraocular que comprende la administracion en forma topica de una composicion farmaceutica que comprende 4-bromo-5-(2-imidazolin-2-ilamin)benzimidazol, en donde el ojo afectado tiene una presion intraocular inferior a la de la linea base; y articulo de elaboracion que comprende a dicha composicion. | |
AR107858A1 (es) | Placa de yeso y un proceso para la fabricación | |
CR10774A (es) | Mandriles y su uso en el procesado de estructuras toroidales | |
AR097250A1 (es) | Sistemas y métodos para solicitar una comunicación | |
AR097745A1 (es) | Métodos de mantenimiento del pozo y composiciones que contienen polímeros degradables | |
ECSP13012849A (es) | Aleta e instalación para la conversión de energía hidráulica que comprende dicha aleta |